Who are Meningococcal vaccine GSK 134612's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): GSK Biologicals' meningococcal vaccine GSK134612.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/meningococcal-vaccine-gsk-134612.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Meningococcal vaccine GSK 134612 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meningococcal vaccine GSK 134612 (Meningococcal vaccine GSK 134612) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Meningococcal vaccine. Area: Immunology.

phase 3 Meningococcal vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Meningococcal vaccine GSK 134612 (Meningococcal vaccine GSK 134612) — GlaxoSmithKline. This vaccine stimulates the immune system to produce antibodies against meningococcal antigens, providing protection against meningococcal disease.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Meningococcal vaccine GSK 134612 TARGET	Meningococcal vaccine GSK 134612	GlaxoSmithKline	phase 3	Meningococcal vaccine
GSK Biologicals' meningococcal vaccine GSK134612	GSK Biologicals' meningococcal vaccine GSK134612	GlaxoSmithKline	phase 3	Meningococcal vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Meningococcal vaccine class)

GlaxoSmithKline · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Meningococcal vaccine GSK 134612 — Competitive Intelligence Brief. https://druglandscape.com/ci/meningococcal-vaccine-gsk-134612. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab